Related news from
Wed, 18 Mar 2026 02:42:00 +0000	Payoneer, PROG, Hercules Capital, Oaktree Specialty Lending, and Sixth Street Specialty Lending Stocks Trade Up, What You Need To Know A number of stocks jumped in the afternoon session after the broader market advanced amid a more stable investor response to geopolitical tensions.
Mon, 16 Mar 2026 22:09:14 +0000	UBS Cuts Hercules Capital (HTGC) Target as BDC Outlook Remains Mixed Hercules Capital, Inc. (NYSE:HTGC) is included among the 13 Extreme Dividend Stocks with Huge Upside Potential. On March 13, UBS lowered its price recommendation on Hercules Capital, Inc. (NYSE:HTGC) to $15 from $19.50. The firm maintained a Neutral rating on the shares. During the Q4 2025 earnings call, CEO Scott Bluestein said the company delivered […]
Fri, 13 Mar 2026 15:21:00 +0000	CION Investment Stock Plunges on Q4 Earnings Miss, Expenses Decline Y/Y CION stock dips 9.9% as Q4 net investment income misses estimates, along with a decline in total investment income. Yet, lower operating costs offered some support.
Tue, 10 Mar 2026 13:30:04 +0000	Is Hercules Capital (HTGC) a Buy as Wall Street Analysts Look Optimistic? Based on the average brokerage recommendation (ABR), Hercules Capital (HTGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Tue, 10 Mar 2026 06:25:00 +0000	1 Sizzling 12.7% Ultra-High-Yield Dividend Stock to Buy Hand Over Fist Right Now Hercules Capital is a leading business development company funding software and life sciences businesses.
Tue, 10 Mar 2026 05:09:13 +0000	Hercules Capital Faces Rising Short Interest As Valuation Discount Widens Short interest in Hercules Capital, NYSE:HTGC, has risen, pointing to increased bearish positioning in the stock. High profile commentator Jim Cramer has publicly criticized Hercules Capital and the broader business development company sector. The combination of higher short interest and critical commentary is drawing attention to risk perceptions and transparency questions around NYSE:HTGC. Hercules Capital shares recently closed at $14.67, with the stock showing a 10.8% decline over the...
Tue, 10 Mar 2026 04:36:56 +0000	Is Hercules Capital (HTGC) Pricing Reflect Its Role Funding Tech And Life Sciences Growth? If you are looking at Hercules Capital and wondering whether the current share price reflects its true value, you are not alone. This article breaks down what that might mean for you as an investor. The stock most recently closed at US$14.67, with returns of 0.5% over 7 days, a 10.8% decline over 30 days, a 22.2% decline year to date, a 12.0% decline over 1 year, and gains of 76.1% over 3 years and 53.6% over 5 years. Recent headlines around Hercules Capital have focused on its role as a...
Tue, 10 Mar 2026 01:09:50 +0000	Should Short-Seller Pressure and Cramer’s Critique of BDCs Require Action From Hercules Capital (HTGC) Investors? In early March 2026, Hercules Capital, Inc., a business development company focused on venture and growth lending, came under pressure as short interest in its shares rose sharply and TV commentator Jim Cramer urged investors to avoid business development companies due to perceived opacity and risk in their underlying portfolios. This combination of rising bearish positioning and high-profile criticism has thrown fresh attention on how clearly Hercules’ investments are understood and how...
Mon, 09 Mar 2026 17:14:00 +0000	CION Investment to Report Q4 Earnings: What's in Store for the Stock? CION is set to post Q4 results, with earnings expected to rise year over year but revenues projected to fall amid rising non-accruals.
Mon, 09 Mar 2026 11:00:00 +0000	enGene Reports First Quarter 2026 Financial Results and Provides Business Update BOSTON & MONTREAL, March 09, 2026--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the first quarter ended January 31, 2026, and provided a business update.
Sun, 08 Mar 2026 16:34:29 +0000	Jim Cramer on Hercules Capital: “I Want You to Stay Away From These” Hercules Capital, Inc. (NYSE:HTGC) is one of the stocks Jim Cramer talked about. Answering a caller’s query regarding the stock, Cramer stated: No, this is a business development company. We’ve disliked these for 21 years now… There was one today that we talked about with, that BlackRock did. I want you to stay away from […]
Wed, 04 Mar 2026 17:16:00 +0000	Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS SAN MATEO, Calif., March 04, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Morningstar DBRS ("DBRS") has affirmed Hercules’ investment grade corporate and credit rating of BBB (high). DBRS issued a statement announcing the a
Wed, 04 Mar 2026 04:37:18 +0000	Assessing Hercules Capital (HTGC) Valuation After Short Report Challenges Dividend And Loan Book Hercules Capital (HTGC) is back in focus after a Hunterbrook short report challenged how it values its software loan book and funds its dividend, prompting a detailed rebuttal from the company and sharpening questions about portfolio risk. See our latest analysis for Hercules Capital. The share price has come under pressure recently, with a 30 day share price return of 21.64% and year to date share price return of 23.01%, even though the 5 year total shareholder return of 60.17% is still...
Mon, 02 Mar 2026 15:55:00 +0000	Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor SAN MATEO, Calif., March 02, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, was named 2025 BDC Manager of the Year - Americas by Private Debt Investor magazine.
Mon, 02 Mar 2026 15:23:12 +0000	Goldman Questions MoonLake Immunotherapeutics’ (MLTX) Sonelokimab Approval Odds Despite Pipeline Update MoonLake Immunotherapeutics (NASDAQ:MLTX) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. MoonLake Immunotherapeutics (NASDAQ:MLTX) is placed eighth on our list of most promising stocks. TheFly reported on February 26 that Goldman Sachs increased its price target on MLTX to $11 from $10 and maintained a Sell rating. The update followed […]
Mon, 02 Mar 2026 11:44:43 +0000	1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Fri, 27 Feb 2026 23:26:32 +0000	Hercules Capital and Sallie Mae Shares Are Falling, What You Need To Know A number of stocks fell in the afternoon session after the release of a stronger-than-anticipated Producer Price Index (PPI) report showed wholesale inflation rose more than expected in January.
Fri, 27 Feb 2026 17:56:00 +0000	Main Street Capital Q4 Earnings Beat, Shares Fall as Expenses Rise Y/Y MAIN's Q4 results benefit from higher investment income. However, the stock lost nearly 1.5% as expenses increased year over year.
Wed, 25 Feb 2026 22:09:36 +0000	How The Hercules Capital (HTGC) Story Is Shifting As Analysts Rework Growth And Valuation Assumptions The consolidated fair value estimate for Hercules Capital has been reset from US$21.22 to US$20.31 per share, a modest pullback that still keeps the stock’s modeled target level close to prior assumptions. Analysts are split, with some treating the roughly US$1 shift as a measured recalibration and others viewing it as part of a more cautious stance on execution. As you read on, you will see how this price target move fits into the evolving narrative and what signals to watch next. Analyst...
Wed, 25 Feb 2026 05:28:21 +0000	Piper Sandler Downgrades Hercules Capital, Inc. (HTGC) to Neutral and Lowers its Price Target to $17.50 Hercules Capital, Inc. (NYSE:HTGC) is among the 11 High Growth Financial Stocks to Buy Now. On February 13, 2026, Piper Sandler downgraded Hercules Capital, Inc. (NYSE:HTGC) to Neutral from Overweight and lowered the price target to $17.50 from $20.50 following the Q4 report. Piper Sandler noted the company’s 35% exposure to software could create “negative […]

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like BDCs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!